Establishment and characterization of arsenic trioxide resistant KB/ATO cells
Arsenic trioxide (ATO) is used as a chemotherapeutic agent for the treatment of acute promyelocytic leukemia. However, increasing drug resistance is reducing its efficacy. Therefore, a better understanding of ATO resistance mechanism is required. In this study, we established an ATO-resistant human...
Saved in:
Main Authors: | Yun-Kai Zhang (Author), Chunling Dai (Author), Chun-gang Yuan (Author), Hsiang-Chun Wu (Author), Zhijie Xiao (Author), Zi-Ning Lei (Author), Dong-Hua Yang (Author), X. Chris Le (Author), Liwu Fu (Author), Zhe-Sheng Chen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dose Response of MTLN3 Cells to Serial Dilutions of Arsenic Trioxide and Ionizing Radiation
by: Waseem Khan Raja, et al.
Published: (2013) -
Single Cell RNA-Seq Analysis Identifies Differentially Expressed Genes of Treg Cell in Early Treatment-Naive Rheumatoid Arthritis By Arsenic Trioxide
by: Chunling Li, et al.
Published: (2021) -
Cytotoxicity patterns of arsenic trioxide exposure on HaCaT keratinocytes
by: Udensi UK, et al.
Published: (2011) -
Evaluation of chronic toxicity of Kushta Sammulfar (calx of Arsenic trioxide)
by: Athar Parvez Ansari, et al.
Published: (2013) -
Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal
by: Degang Kong, et al.
Published: (2020)